Imipenem and expression of multidrug efflux pump in Enterobacter aerogenes

被引：65

作者：

Bornet, C ^{[1
]}

Chollet, R ^{[1
]}

Malléa, M ^{[1
]}

Chevalier, J ^{[1
]}

Davin-Regli, A ^{[1
]}

Pagès, JM ^{[1
]}

Bollet, C ^{[1
]}

机构：

[1] Univ Mediterranee, Fac Med, EA2197, IFR48, F-13385 Marseille 05, France

来源：

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 2003年 / 301卷 / 04期

关键词：

efflux pump; Enterobacter aerogenes; imipenem; efflux pump inhibitor; multidrug resistance;

D O I：

10.1016/S0006-291X(03)00074-3

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

imipenem is often used to treat intensive care unit patients infected by Enterobacter aerogenes, but it is leading to an increasing number of antibiotic resistant strains. Clinical isolates and imipenem resistant variants presented a high level of resistance to P-lactam antibiotic group and to chemically unrelated drugs. We report here that imipenem selects strains which contain active efflux pumps ejecting various unrelated antibiotics including quinolones, tetracycline, and chloramphenicol. An increase of AcrA, an efflux pump component, was observed in the imipenem resistant variants. The overexpression of marA, involved in the genetic control of membrane permeability via porin and efflux pump expression, indicated the activation of the resistance genetic cascade in imipenem resistant variants. (C) 2003 Elsevier Science (USA). All rights reserved.

引用

页码：985 / 990

页数：6

共 25 条

[11] MULTIDRUG-RESISTANCE IN KLEBSIELLA-PNEUMONIAE - A NOVEL GENE, RAMA, CONFERS A MULTIDRUG-RESISTANCE PHENOTYPE IN ESCHERICHIA-COLI [J].

GEORGE, AM ;

HALL, RM ;

STOKES, HW .

MICROBIOLOGY-UK, 1995, 141 :1909-1920

[12] Direct quantitative transcript analysis of the agr regulon of Staphylococcus aureus during human infection in comparison to the expression profile in vitro [J].

Goerke, C ;

Campana, S ;

Bayer, MG ;

Döring, G ;

Botzenhart, K ;

Wolz, C .

INFECTION AND IMMUNITY, 2000, 68 (03) :1304-1311

[13] ENHANCED RESISTANCE TO CEFOTAXIME AND IMIPENEM ASSOCIATED WITH OUTER-MEMBRANE PROTEIN ALTERATIONS IN ENTEROBACTER-AEROGENES [J].

HOPKINS, JM ;

TOWNER, KJ .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 (01) :49-55

[14] Molecular epidemiological study of nosocomial Enterobacter aerogenes isolates in a Belgian hospital [J].

Jalaluddin, S ;

Devaster, JM ;

Scheen, R ;

Gerard, M ;

Butzler, JP .

JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (07) :1846-1852

[15] CARBAPENEM RESISTANCE IN ENTEROBACTER-AEROGENES IS DUE TO LIPOPOLYSACCHARIDE ALTERATIONS [J].

LEYING, H ;

CULLMANN, W ;

DICK, W .

CHEMOTHERAPY, 1991, 37 (02) :106-113

[16] Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa:: Novel agents for combination therapy [J].

Lomovskaya, O ;

Warren, MS ;

Lee, A ;

Galazzo, J ;

Fronko, R ;

Lee, M ;

Blais, J ;

Cho, D ;

Chamberland, S ;

Renau, T ;

Leger, R ;

Hecker, S ;

Watkins, W ;

Hoshino, K ;

Ishida, H ;

Lee, VJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) :105-116

[17] Porin alteration and active efflux:: two in vivo drug resistance strategies used by Enterobacter aerogenes [J].

Mallea, M ;

Chevalier, J ;

Bornet, C ;

Eyraud, A ;

Davin-Regli, A ;

Bollet, C ;

Pagès, JM .

MICROBIOLOGY-UK, 1998, 144 :3003-3009

[18] Inhibitors of antibiotic efflux pump in resistant Enterobacter aerogenes strains [J].

Malléa, M ;

Chevalier, J ;

Eyraud, A ;

Pagès, JM .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 293 (05) :1370-1373

[19] Identification of mar mutants among quinolone-resistant clinical isolates of Escherichia coli [J].

Maneewannakul, K ;

Levy, SB .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (07) :1695-1698

[20] The AcrAB-TolC efflux pump contributes to multidrug resistance in the nosocomial pathogen Enterobacter aerogenes [J].

Pradel, E ;

Pagès, JM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (08) :2640-2643

← 1 2 3 →